Chikungunya Diagnostic Test Kit Suppliers & Bulk Manufacturers
Available Forms: Test Kits
Available Strengths: Detect IgM and IgG antibodies
Reference Brands: SD Biosensor
Category:
Rapid Test Kits
The Chikungunya IgM Rapid Test Cassette is a lateral flow chromatographic immunoassay for the qualitative detection of IgM anti-chikungunya virus (CHIK) in human serum, plasma or whole blood. It is intended to be used as a screening test and as an aid in the diagnosis of infection with CHIK.
Chikungunya Diagnostic Test Kit is available in Test Kits
and strengths such as Detect IgM and IgG antibodies.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Chikungunya Diagnostic Test Kit is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Chikungunya Diagnostic Test Kit can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Chikungunya test kits in the EU and US are regulated to ensure safety, efficacy, and quality. In the US, FDA approval involves validation, safety testing, and GMP compliance, while in the EU, CE marking certifies conformity with MDR standards. These devices undergo validation, performance testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to reliable, high-quality chikungunya testing solutions, supporting disease surveillance and outbreak control efforts worldwide, and enabling timely diagnosis to prevent spread in both healthcare and field settings.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing